Role of Reactive Oxygen Species in Endothelin-Induced Hypertension
ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.806-810 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 810 |
---|---|
container_issue | 4, Part 2 |
container_start_page | 806 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 42 |
creator | Sedeek, Mona H Llinas, Maria T Drummond, Heather Fortepiani, Lourdes Abram, Sean R Alexander, Barbara T Reckelhoff, Jane F Granger, Joey P |
description | ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin. |
doi_str_mv | 10.1161/01.HYP.0000084372.91932.BA |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_205273906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>420432041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</originalsourceid><addsrcrecordid>eNpFkN1q20AQRpfQkLhpXqGIQC-lzOyPVts7O6R1IJCSttBcLevVqFaqSM6u1NRv301s8NwMM5yZDw5jFwgFYomXgMXy4VsBr1VJoXlh0AheLOZHbIaKy1yqUrxjM0Ajc4P465S9j_ERAKWU-oSdIq-0BFPO2OJ-6CgbmuyenB_bv5Td_dv-pj77viHfUszaPrvu62FcU9f2-U1fT57qbLndUBipj-3Qf2DHjesine_7Gfv55frH1TK_vft6czW_zb3SJeRGqhU0Ta2MA8M11qgaLbwXyJ2ouNM1NYogDc2KeyMrXVZUyhoUyBJVJc7Yxe7vJgzPE8XRPg5T6FOk5aC4FgbKBH3eQT4MMQZq7Ca0Ty5sLYJ9tWcBbbJnD_bsmz27mKfjj_uEafVE9eF0rysBn_aAi951TXC9b-OBU1gJAJ44ueNehm6kEP900wsFuybXjeu3aMnLKucAAhMPedoIEP8BcL2GLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205273906</pqid></control><display><type>article</type><title>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Ovid Autoload</source><creator>Sedeek, Mona H ; Llinas, Maria T ; Drummond, Heather ; Fortepiani, Lourdes ; Abram, Sean R ; Alexander, Barbara T ; Reckelhoff, Jane F ; Granger, Joey P</creator><creatorcontrib>Sedeek, Mona H ; Llinas, Maria T ; Drummond, Heather ; Fortepiani, Lourdes ; Abram, Sean R ; Alexander, Barbara T ; Reckelhoff, Jane F ; Granger, Joey P</creatorcontrib><description>ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.0000084372.91932.BA</identifier><identifier>PMID: 12874096</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Animals ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cells, Cultured ; Chronic Disease ; Cyclic N-Oxides - pharmacology ; Dinoprost - analogs & derivatives ; Endothelin-1 - pharmacology ; Endothelin-1 - toxicity ; Experimental diseases ; F2-Isoprostanes - urine ; Free Radical Scavengers - pharmacology ; Hemodynamics - drug effects ; Hypertension - chemically induced ; Hypertension - metabolism ; Hypertension - physiopathology ; Kidney - metabolism ; Kidney - physiopathology ; Male ; Medical sciences ; Muscle, Smooth, Vascular - metabolism ; Rats ; Rats, Sprague-Dawley ; Reactive Oxygen Species - metabolism ; Spin Labels ; Superoxides - metabolism ; Thiobarbituric Acid Reactive Substances - metabolism ; Vasoconstrictor Agents - pharmacology ; Vasoconstrictor Agents - toxicity</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.806-810</ispartof><rights>2003 American Heart Association, Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Oct 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</citedby><cites>FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3673,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15183002$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12874096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sedeek, Mona H</creatorcontrib><creatorcontrib>Llinas, Maria T</creatorcontrib><creatorcontrib>Drummond, Heather</creatorcontrib><creatorcontrib>Fortepiani, Lourdes</creatorcontrib><creatorcontrib>Abram, Sean R</creatorcontrib><creatorcontrib>Alexander, Barbara T</creatorcontrib><creatorcontrib>Reckelhoff, Jane F</creatorcontrib><creatorcontrib>Granger, Joey P</creatorcontrib><title>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.</description><subject>Animals</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cells, Cultured</subject><subject>Chronic Disease</subject><subject>Cyclic N-Oxides - pharmacology</subject><subject>Dinoprost - analogs & derivatives</subject><subject>Endothelin-1 - pharmacology</subject><subject>Endothelin-1 - toxicity</subject><subject>Experimental diseases</subject><subject>F2-Isoprostanes - urine</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Hemodynamics - drug effects</subject><subject>Hypertension - chemically induced</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>Kidney - metabolism</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Spin Labels</subject><subject>Superoxides - metabolism</subject><subject>Thiobarbituric Acid Reactive Substances - metabolism</subject><subject>Vasoconstrictor Agents - pharmacology</subject><subject>Vasoconstrictor Agents - toxicity</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkN1q20AQRpfQkLhpXqGIQC-lzOyPVts7O6R1IJCSttBcLevVqFaqSM6u1NRv301s8NwMM5yZDw5jFwgFYomXgMXy4VsBr1VJoXlh0AheLOZHbIaKy1yqUrxjM0Ajc4P465S9j_ERAKWU-oSdIq-0BFPO2OJ-6CgbmuyenB_bv5Td_dv-pj77viHfUszaPrvu62FcU9f2-U1fT57qbLndUBipj-3Qf2DHjesine_7Gfv55frH1TK_vft6czW_zb3SJeRGqhU0Ta2MA8M11qgaLbwXyJ2ouNM1NYogDc2KeyMrXVZUyhoUyBJVJc7Yxe7vJgzPE8XRPg5T6FOk5aC4FgbKBH3eQT4MMQZq7Ca0Ty5sLYJ9tWcBbbJnD_bsmz27mKfjj_uEafVE9eF0rysBn_aAi951TXC9b-OBU1gJAJ44ueNehm6kEP900wsFuybXjeu3aMnLKucAAhMPedoIEP8BcL2GLg</recordid><startdate>200310</startdate><enddate>200310</enddate><creator>Sedeek, Mona H</creator><creator>Llinas, Maria T</creator><creator>Drummond, Heather</creator><creator>Fortepiani, Lourdes</creator><creator>Abram, Sean R</creator><creator>Alexander, Barbara T</creator><creator>Reckelhoff, Jane F</creator><creator>Granger, Joey P</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>200310</creationdate><title>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</title><author>Sedeek, Mona H ; Llinas, Maria T ; Drummond, Heather ; Fortepiani, Lourdes ; Abram, Sean R ; Alexander, Barbara T ; Reckelhoff, Jane F ; Granger, Joey P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cells, Cultured</topic><topic>Chronic Disease</topic><topic>Cyclic N-Oxides - pharmacology</topic><topic>Dinoprost - analogs & derivatives</topic><topic>Endothelin-1 - pharmacology</topic><topic>Endothelin-1 - toxicity</topic><topic>Experimental diseases</topic><topic>F2-Isoprostanes - urine</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Hemodynamics - drug effects</topic><topic>Hypertension - chemically induced</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>Kidney - metabolism</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Spin Labels</topic><topic>Superoxides - metabolism</topic><topic>Thiobarbituric Acid Reactive Substances - metabolism</topic><topic>Vasoconstrictor Agents - pharmacology</topic><topic>Vasoconstrictor Agents - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sedeek, Mona H</creatorcontrib><creatorcontrib>Llinas, Maria T</creatorcontrib><creatorcontrib>Drummond, Heather</creatorcontrib><creatorcontrib>Fortepiani, Lourdes</creatorcontrib><creatorcontrib>Abram, Sean R</creatorcontrib><creatorcontrib>Alexander, Barbara T</creatorcontrib><creatorcontrib>Reckelhoff, Jane F</creatorcontrib><creatorcontrib>Granger, Joey P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sedeek, Mona H</au><au>Llinas, Maria T</au><au>Drummond, Heather</au><au>Fortepiani, Lourdes</au><au>Abram, Sean R</au><au>Alexander, Barbara T</au><au>Reckelhoff, Jane F</au><au>Granger, Joey P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2003-10</date><risdate>2003</risdate><volume>42</volume><issue>4, Part 2</issue><spage>806</spage><epage>810</epage><pages>806-810</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>12874096</pmid><doi>10.1161/01.HYP.0000084372.91932.BA</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.806-810 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_journals_205273906 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Ovid Autoload |
subjects | Animals Arterial hypertension. Arterial hypotension Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cells, Cultured Chronic Disease Cyclic N-Oxides - pharmacology Dinoprost - analogs & derivatives Endothelin-1 - pharmacology Endothelin-1 - toxicity Experimental diseases F2-Isoprostanes - urine Free Radical Scavengers - pharmacology Hemodynamics - drug effects Hypertension - chemically induced Hypertension - metabolism Hypertension - physiopathology Kidney - metabolism Kidney - physiopathology Male Medical sciences Muscle, Smooth, Vascular - metabolism Rats Rats, Sprague-Dawley Reactive Oxygen Species - metabolism Spin Labels Superoxides - metabolism Thiobarbituric Acid Reactive Substances - metabolism Vasoconstrictor Agents - pharmacology Vasoconstrictor Agents - toxicity |
title | Role of Reactive Oxygen Species in Endothelin-Induced Hypertension |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A05%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Reactive%20Oxygen%20Species%20in%20Endothelin-Induced%20Hypertension&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Sedeek,%20Mona%20H&rft.date=2003-10&rft.volume=42&rft.issue=4,%20Part%202&rft.spage=806&rft.epage=810&rft.pages=806-810&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.0000084372.91932.BA&rft_dat=%3Cproquest_cross%3E420432041%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205273906&rft_id=info:pmid/12874096&rfr_iscdi=true |